Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial - Mechanisms and implications

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 5, 2003, Pages 357-362

  DeVries, J Hans ^a   Snoek, Frank J ^a   Kostense, Piet J ^a   Heine, Robert J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glycaemic control; Good clinical practice; Insulin therapy; Quality of life; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART;

ADULT; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DIABETES CONTROL; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GOOD CLINICAL PRACTICE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; SELF CARE; SELF MONITORING; TIME;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 0141836724     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.405     Document Type: Review

References (29)

1. Anderson JHJ, Brunelle RL, Keohane P, et al., Multicenter Insulin Lispro Study Group. Mealtime treatment with insulin analog improves postprandial hyperglycaemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1249-1255.
2. Heller SR, Amiel SA, Mansell P. U.K. Lispro Study Group. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care 1999; 22: 1607-1611.
3. Ratner RE, Hirsch IB, Neifing JL, et al., U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 2000; 23: 639-643.
4. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 2000; 23: 583-588.
5. Janssen MM, Snoek FJ, Masurel N, et al. Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycaemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction. Diabetes Care 2000; 23: 629-633.
6. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. BMJ 1986; 293: 1195-1199.
7. Cook T, Campbell DT. Quasi-Experimentation. Design and Analysis Issues for Field Settings, Houghton Mifflin Company: Boston, 1979.
8. Worth R, Home PD, Johnston DG, et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. BMJ 1982; 285: 1233-1240.
9. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycaemic control. Diabetes Care 2002; 25: 2074-2080.
10. International Conference on Harmonization (ICH), Topic E6: Harmonized Tripartite Guideline for Good Clinical Practice. Step 5, Consolidated Guideline 1.5.96, EMEA: London, 1996.
11. Bradley C. Diabetes treatment satisfaction questionnaire (DTSQ). Handbook of Psychology and Diabetes, Harwood Academic Publishers: Chur, Switzerland, 1994; 111-132.
12. Pouwer F, Snoek FJ, van der Ploeg HM, Heine RJ, Brand AN. A comparison of the standard and the computerized versions of the well-being questionnaire (WBQ) and the diabetes treatment satisfaction questionnaire (DTSQ). Qual Life Res 1998; 7: 33-38.
13. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995; 18: 754-760.
14. Welch GW. The diabetes coping measure. In Handbook of Psychology and Diabetes, Bradley C (ed). Harwood Academic Publishers: Chur, Switzerland, 1994; 400.
15. SPSS BASE 9.0 Applications Guide. SPSS: Chicago, 2000.
16. Roethisberger FB, Dickson WJ, Management and the Worker, Harvard University Press: Cambridge, MA, 1939.
17. Jorde R, Sundsfjord J. Intra-individual variability and longitudinal changes in glycaemic control in patients with type 1 diabetes mellitus. Diabet Med 2000; 17: 451-456.
18. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563-2569.
19. Bradley C. Designing medical and educational intervention studies. A review of some alternatives to conventional randomized controlled trials. Diabetes Care 1993; 16: 509-518.
20. Terent A, Hagfall O, Cederholm U. The effect of education and self-monitoring of blood glucose on glycosylated hemoglobin in type I diabetes. A controlled 18-month trial in a representative population. Acta Med Scand 1985; 217: 47-53.
21. Korhonen T, Huttunen JK, Aro A, et al. A controlled trial on the effects of patient education in the treatment of insulin-dependent diabetes. Diabetes Care 1983; 6: 256-261.
22. de Weerdt I, Visser AP, Kok G, van der Veen EA. Determinants of active self-care behaviour of insulin treated patients with diabetes: implications for diabetes education. Soc Sci Med 1990; 30: 605-615.
23. Gordon D, Semple CG, Paterson KR. Do different frequencies of self-monitoring of blood glucose influence control in type 1 diabetic patients? Diabet Med 1991; 8: 679-682.
24. Rollnick S, Mason P, Butler C. Health Behavior Change. A Guide for Practioners, Churchill Livingstone: Edinburgh, 1999.
25. Glasgow RE, Fisher EB, Anderson BJ, et al. Behavioral science in diabetes. Contributions and opportunities. Diabetes Care 1999; 22: 832-843.
26. Ebeling P, Jansson PA, Smith U, et al. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin. Diabetes Care 1997; 20: 1287-1289.
27. Tamas G, Marre M, Astorga R, et al. Glycaemic control in type 1 diabetic patients using optimized insulin aspart or human insulin in a randomized multinational study. Diabetes Res Clin Pract 2001; 54: 105-114.
28. Home PD, Lindholm A, Riis A. European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 2000; 17: 762-770.
29. De Vries JH, Lindholm A, Jacobsen JL, Heine RJ, Home PD; The Tri-Continental Insulin Aspart Study Group. A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes. Diabet Med 2003; 20: 312-318.